학술논문
15144 Long-term safety of apremilast treatment in patients with psoriasis or psoriatic arthritis: Pooled analysis for 260 weeks and beyond in the ESTEEM 1 and 2 and PALACE 1-4 phase 3 trials
Document Type
Abstract
Author
Source
In Journal of the American Academy of Dermatology December 2020 83(6) Supplement:AB30-AB30
Subject
Language
ISSN
0190-9622